Explore 3 Stock Ideas & Industry Insights Download Free Report

800-234-336
Shopping Cart 0
countryflagNZ
Login

Aleafia Health Inc

Healthcare US ALEAF

NoneUSD
0.00(0%)

Last update at 2024-09-11T10:46:25.744929Z

Day Range

--
LowHigh

52 Week Range

0.010.07
LowHigh

Fundamentals

  • Previous Close -
  • Market Cap6.09M
  • VolumeNone
  • P/E Ratio-
  • Dividend Yield-%
  • EBITDA-11.77900M
  • Revenue TTM42.85M
  • Revenue Per Share TTM0.11
  • Gross Profit TTM -9.55520M
  • Diluted EPS TTM-0.07

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Analyst Recommendations

Financials

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Type yearly yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Income before tax -34.60700M - -249.77800M -36.64800M -19.54040M
Minority interest - - - - 0.00000M
Net income -34.60700M - -247.23800M -39.60700M -18.53258M
Selling general administrative 17.70M - 31.94M 38.85M 20.01M
Selling and marketing expenses 2.46M - - - 0.93M
Gross profit 6.00M - -5.61000M 20.78M 2.79M
Reconciled depreciation 6.57M - 10.16M 5.91M 1.66M
Ebit -17.53900M -65.18900M 153.75M -23.98300M -19.91024M
Ebitda -10.97400M - 163.92M -17.35200M -18.25124M
Depreciation and amortization 6.57M - 10.16M 6.63M 1.66M
Non operating income net other - - - - 0.00000M
Operating income -17.53900M - 153.75M -23.98300M -19.81024M
Other operating expenses 60.39M - 90.15M 40.33M 23.14M
Interest expense 9.36M 0.00000M 0.00000M 6.38M 0.00000M
Tax provision 0.00000M - -2.54000M 2.96M -1.00783M
Interest income - - - 0.42M 0.17M
Net interest income -9.35700M - -11.63600M -5.95900M 0.17M
Extraordinary items - - - - 0.00000M
Non recurring - - - - 0.00000M
Other items - - - - 0.00000M
Income tax expense 9.36M -2.85400M -2.54000M 2.96M -1.00783M
Total revenue 42.85M - 44.54M 16.35M 3.33M
Total operating expenses 23.54M - 40.00M 44.77M 22.60M
Cost of revenue 36.85M - 50.15M -4.43100M 0.54M
Total other income expense net -7.71100M - -403.53100M -12.66500M 0.10M
Discontinued operations - - - - 0.00000M
Net income from continuing ops -34.60700M - -247.23800M -39.60700M -18.53258M
Net income applicable to common shares - -165.71500M -255.50500M -39.60700M -18.53300M
Preferred stock and other adjustments - - - - 0.00000M
Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Type yearly yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Total assets 59.92M - 237.28M 462.36M 97.86M
Intangible assets - - 54.71M 81.25M 34.37M
Earning assets - - - - -
Other current assets 12.03M 4.01M 5.06M 0.97M 0.23M
Total liab 68.84M - 83.06M 77.84M 5.93M
Total stockholder equity -8.91300M - 154.22M 384.51M 91.93M
Deferred long term liab - - 0.46M 1.04M 0.00000M
Other current liab 4.38M 0.45M 0.07M 0.10M 0.21M
Common stock 408.67M 404.34M 384.26M 371.74M 104.46M
Capital stock 408.67M - 384.26M 371.74M 104.46M
Retained earnings -527.81000M -480.78400M -315.06900M -67.83100M -28.22448M
Other liab - - 2.85M 5.39M 2.44M
Good will - - 11.31M 188.79M 12.71M
Other assets - - 0.00100M 0.00200M 3.75M
Cash 0.47M - 30.53M 41.25M 26.41M
Cash and equivalents - - - - -
Total current liabilities 35.64M 71.40M 45.04M 20.74M 3.49M
Current deferred revenue 10.03M - 0.07M 0.10M 0.21M
Net debt 45.87M - 29.44M 10.97M -26.40698M
Short term debt 13.14M - 24.80M 0.51M 0.00000M
Short long term debt 12.88M - 24.36M - 0.00000M
Short long term debt total 46.34M - 59.97M 52.22M -
Other stockholder equity 110.22M - 85.03M 35.90M 15.70M
Property plant equipment - 44.94M 81.25M 65.41M 13.78M
Total current assets 35.85M 50.02M 82.92M 117.64M 29.25M
Long term investments 2.39M - 6.62M 4.62M 4.00M
Net tangible assets - 13.96M 79.92M 114.47M 44.84M
Short term investments 0.07M - 0.00000M 1.45M 0.00000M
Net receivables 4.28M 9.28M 17.58M 11.35M 2.03M
Long term debt 31.60M - 32.44M 51.01M 0.00000M
Inventory 19.01M 21.54M 29.75M 35.09M 0.59M
Accounts payable 8.09M 23.57M 20.17M 20.13M 3.28M
Total permanent equity - - - - 0.00000M
Noncontrolling interest in consolidated entity - - - - 0.00000M
Temporary equity redeemable noncontrolling interests - - - - 0.00000M
Accumulated other comprehensive income - - - 44.70M 0.00000M
Additional paid in capital - - - - 0.00000M
Common stock total equity - - - - 0.00000M
Preferred stock total equity - - - - 0.00000M
Retained earnings total equity - - - - 0.00000M
Treasury stock - - - - 0.00000M
Accumulated amortization - - - - 0.00000M
Non currrent assets other - - 0.46M 4.65M 3.75M
Deferred long term asset charges - - - - 0.00000M
Non current assets total 24.08M - 154.36M 344.71M 68.62M
Capital lease obligations 1.86M - 3.17M 1.21M 0.00000M
Long term debt total - - - - 0.00000M
Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Type yearly yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Investments -1.42700M - 1.57M 3.14M -4.00000M
Change to liabilities - 5.24M 0.04M 7.64M 1.11M
Total cashflows from investing activities - -4.00700M -16.20500M 15.40M -9.22600M
Net borrowings - -5.18800M -1.13800M 33.20M 6.00M
Total cash from financing activities 3.96M 17.37M 13.12M 34.67M 44.87M
Change to operating activities - 1.43M 35.45M 8.94M -3.88600M
Net income -34.60700M -165.71500M -247.23800M -39.60700M -18.53258M
Change in cash -0.94200M -19.29700M -10.71800M 14.84M 25.35M
Begin period cash flow 1.57M 30.53M 41.25M 26.41M 1.06M
End period cash flow 0.63M 1.57M 30.53M 41.25M 26.41M
Total cash from operating activities -3.47800M -32.66300M -7.62900M -30.85600M -10.29746M
Issuance of capital stock 5.62M - 14.16M 0.14M 38.28M
Depreciation 6.57M 10.28M 10.16M 5.91M 1.66M
Other cashflows from investing activities - - - -0.61800M -0.61800M
Dividends paid 0.00000M - - 0.00000M 0.00000M
Change to inventory -4.36300M -12.65200M -21.59500M -15.30000M -0.58814M
Change to account receivables - -4.82100M -10.11400M -1.47700M -1.05287M
Sale purchase of stock - - - - 0.00000M
Other cashflows from financing activities 1.54M -4.63200M 0.09M 35.23M 10.59M
Change to netincome - 130.70M 235.30M 13.63M 10.76M
Capital expenditures 1.65M 4.01M 17.78M 16.08M 12.14M
Change receivables - - - - 0.00000M
Cash flows other operating - - - - 0.00000M
Exchange rate changes - - - - 0.00000M
Cash and cash equivalents changes - - - - 0.00000M
Change in working capital -2.20300M - -14.84200M -13.83900M -4.41668M
Stock based compensation 2.40M - 2.69M 13.51M 10.78M
Other non cash items 8.34M - 244.14M 0.21M 1.22M
Free cash flow -5.13200M - -25.40600M -46.93300M -22.44065M

Peer Comparison

Sector: Healthcare Industry: Drug Manufacturers - Specialty & Generic

Company Change (USD) Price (USD) Trailing PE (x) Forward PE (x) Price Sales TTM (x) Price to Book Value (x) Enterprise Value to Revenue (x) Enterprise Value to EBITDA (x)
ALEAF
Aleafia Health Inc		 - -% - - - 0.14 1.11 0.91 -2.0785
ZTS
Zoetis Inc		 -2.82 3.58% 75.89 40.18 30.96 10.67 17.60 11.27 26.18
MKKGY
Merck KGaA ADR		 -0.19 0.62% 30.56 21.25 14.93 3.10 2.14 3.60 12.98
MKGAF
MERCK Kommanditgesellschaft auf Aktien		 - -% 157.12 21.73 14.95 3.16 2.15 3.56 12.82
GALDY
GALDERMA GROUP AG		 - -% 42.94 74.21 41.67 8.64 5.55 9.15 42.22

Reports Covered

Stock Research & News

View All

Profile

Aleafia Health Inc., together with its subsidiaries, operates as cannabis health and wellness company in Canada, Europe, and Australia. The company owns and operates a virtual network of medical cannabis clinics staffed through physicians and nurse practitioners. Its product portfolio includes cannabis oils, capsules, edibles, cannabis-infused sublingual strips, pre-roll, milled, and vape cartridges; bath bombs and soft gels; hang dried, hand trimmed, long cured, and small batch dried flower; and concentrates. It offers its products under the Divvy, Sunday Market, Bogart's Kitchen, Noon & Night, Nith & Grand, Kin Slips, and Emblem brands. Aleafia Health Inc. is headquartered in Concord, Canada.

Aleafia Health Inc

85 Basaltic Road, Concord, ON, Canada, L4K 1G4

Key Executives

Name Title Year Born
Ms. Patricia Symmes Chief Exec. Officer NA
Mr. Matthew Sale Chief Financial Officer NA
Mr. Nicholas Bergamini Vice-Pres of Investor Relations & Communications NA
Mr. David Shepherd Sr. VP of HR NA

Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.